Correspondence 0001493152-24-040408 from Calidi Biotherapeutics, Inc. (CLDI)
Calidi Biotherapeutics, Inc.
Date: Oct. 8, 2024 · CIK: 0001855485 · Accession: 0001493152-24-040408
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-282456
Letter
October 8, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Technology
F Street NE
Washington, D.C. 20549
Attention: Doris Stacey Gama
Re: Calidi Biotherapeutics, Inc.
Registration Statement on Form S-3
File No. 333-282456
Filed on October 1, 2024, as amended October 7, 2024
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), Calidi Biotherapeutics, Inc. (the “Registrant”) hereby requests that the United States Securities and Exchange Commission (the “Commission”) take appropriate action to accelerate the effective date of the above-referenced registration statement (the “Registration Statement”) so as to become effective on Thursday, October 10, 2024, at 5:00 p.m. Eastern Time, or as soon thereafter as practicable. Once the Registration Statement has been declared effective, please confirm orally that event with our counsel, Sichenzia Ross Ference Carmel LLP., by calling Jay K. Yamamoto, Esq. at 212-930-9700.
Very
truly yours,
/s/
Andrew Jackson
Show Raw Text
CORRESP
1
filename1.htm
October
8, 2024
VIA
EDGAR
U.S.
Securities and Exchange Commission
Division
of Corporation Finance
Office
of Technology
100
F Street NE
Washington,
D.C. 20549
Attention:
Doris Stacey Gama
Re:
Calidi
Biotherapeutics, Inc.
Registration
Statement on Form S-3
File
No. 333-282456
Filed
on October 1, 2024, as amended October 7, 2024
Ladies
and Gentlemen:
Pursuant
to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), Calidi Biotherapeutics,
Inc. (the “Registrant”) hereby requests that the United States Securities and Exchange Commission (the “Commission”)
take appropriate action to accelerate the effective date of the above-referenced registration statement (the “Registration Statement”)
so as to become effective on Thursday, October 10, 2024, at 5:00 p.m. Eastern Time, or as soon thereafter as practicable. Once the Registration
Statement has been declared effective, please confirm orally that event with our counsel, Sichenzia Ross Ference Carmel LLP., by calling
Jay K. Yamamoto, Esq. at 212-930-9700.
Very
truly yours,
/s/
Andrew Jackson
Andrew Jackson
Chief
Financial Officer